SCHEMBL2658514

SCHEMBL2658514

Cc1ccc(-c2c(F)ccc3c(N)c4c(nc23)CN(C2=CC=C2)C4=O)cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2657148 0.88 MTOR (0.35) —
SCHEMBL2658291 0.81 CA1 (0.35) —
SCHEMBL2658045 0.81 GABRG2 (0.34) —
SCHEMBL2660434 0.80 BMPR1A (0.38) —
SCHEMBL2660626 0.79 GABRG2 (0.37) —
SCHEMBL2660243 0.79 — —
SCHEMBL2655882 0.78 MTOR (0.36) —
SCHEMBL2659065 0.78 GABRG2 (0.34) —
SCHEMBL2656719 0.77 GABRG2 (0.39) —
SCHEMBL2658971 0.77 GABRG2 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2176263-A2 FUSED QUINOLINE DERIVATIVES USEFUL AS GABA MODULATORS AstraZeneca AB (SE) 2010-04-21 — — EP claimed
US-20080318943-A1 Compounds and Uses Thereof - 848 ASTRAZENECA AB (SE) 2008-12-25 — — US claimed
WO-2008155572-A2 FUSED QUINOLINE DERIVATIVES USEFUL AS GABA MODULATORS ASTRAZENECA AB (SE) 2008-12-24 — — WO claimed
EP-2176263-A2 FUSED QUINOLINE DERIVATIVES USEFUL AS GABA MODULATORS AstraZeneca AB (SE) 2010-04-21 — — EP disclosed
US-20080318943-A1 Compounds and Uses Thereof - 848 ASTRAZENECA AB (SE) 2008-12-25 — — US disclosed
WO-2008155572-A2 FUSED QUINOLINE DERIVATIVES USEFUL AS GABA MODULATORS ASTRAZENECA AB (SE) 2008-12-24 — — WO disclosed
Send feedback